Fresenius Asks Chancery For Fast Akorn Damages Ruling
Pointing to concerns over generic-drug maker Akorn Inc.'s financial outlook, Fresenius Kabi AG told the Chancery Court late Tuesday it wants an expedited ruling on damages claims arising from the two...To view the full article, register now.
Already a subscriber? Click here to view full article